Park Ha Biological Technology Files 2024 Annual Report

Ticker: BYAH · Form: 20-F · Filed: Feb 24, 2025 · CIK: 1986247

Sentiment: neutral

Topics: annual-report, 20-f, cosmetics

TL;DR

Park Ha Bio filed its 2024 20-F, check it for cosmetics biz health.

AI Summary

Park Ha Biological Technology Co., Ltd. filed its annual report on Form 20-F for the fiscal year ended October 31, 2024. The company, incorporated in F4 and headquartered in Wuxi City, China, operates in the soap, detergent, cleaning preparations, perfumes, and cosmetics industry. The filing was made on February 24, 2025, under SEC file number 001-42453.

Why It Matters

This filing provides investors with a comprehensive overview of Park Ha Biological Technology's performance and financial standing for the fiscal year 2024, crucial for assessing its current market position and future prospects.

Risk Assessment

Risk Level: medium — As a foreign private issuer filing a 20-F, the company operates under different regulatory and disclosure standards than domestic US companies, which can introduce additional complexities and risks for investors.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Park Ha Biological Technology Co., Ltd.?

Park Ha Biological Technology Co., Ltd. is primarily involved in the soap, detergent, cleaning preparations, perfumes, and cosmetics industry, as indicated by its SIC code [2840].

What is the fiscal year end for this 20-F filing?

The fiscal year end for this 20-F filing is October 31, 2024.

When was this Form 20-F filed with the SEC?

This Form 20-F was filed with the SEC on February 24, 2025.

What is the company's SEC file number?

The company's SEC file number is 001-42453.

Where is Park Ha Biological Technology Co., Ltd. located?

The company's business and mailing address is located at No. 50 Xiuxi Road, 14F, Building 3, Wuxi City, F4, 214135.

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on February 24, 2025 regarding Park Ha Biological Technology Co., Ltd. (BYAH).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing